In re Pharmaceutical Indus. Avg. Wholesale Price

Decision Date21 June 2007
Docket NumberCivil Action No. 01-12257-PBS.,M.D.L. No. 1456.
Citation491 F.Supp.2d 20
PartiesIn re PHARMACEUTICAL INDUSTRY AVERAGE WHOLESALE PRICE LITIGATION. This Document Relates to: All Actions. Trial of Class 2 and Class 3 Claims.
CourtU.S. District Court — District of Massachusetts

Jeffrey B. Aaronson, Bell, Boyd & Lloyd, Chicago, IL, for Baxter International, Inc. (Defendant).

Marc E. Ackerman, Harris Beach LLP, New York, NY, for Sandoz, Inc. (Consolidated Defendant).

Joseph G. Adams, Snell & Wilmer LLP, Phoenix, AZ, for Pharmacia & Upjohn, Inc. (Consolidated Defendant).

Pamela Zorn Adams, Sherin and Lodgen, Street Boston, MA, for Pharmacia Corporation (Consolidated Defendant), Gensia Sicor Pharmaceuticals, Inc. (Defendant).

Kenneth W. Africano, Harter, Secrest Law, Buffalo, NY, for Sicor, Inc. (Defendant), Ivax Corp. (Defendant), Teva Pharmaceuticals USA, Inc. (Defendant), Ivax Corp. (Defendant), Teva Pharmaceuticals USA, Inc. (Defendant), Ivax Pharmaceuticals, Inc. (Defendant), Allergan Inc. (Consolidated Defendant).

Kevin N. Ainsworth, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Chrysler, New York, NY, for Bayer Corporation (Consolidated Defendant), Novo Nordisk Pharmaceuticals, Inc. (Consolidated Defendant), Eli Lilly and Company (Consolidated Defendant).

Neil Alden, Bowman and Brooke LLP, Phoenix, AZ, for Baxter Healthcare Corp. (Consolidated Defendant).

Jarrett C. Anderson, Anderson LLC, Austin, TX, for Baxter International, Inc. (Defendant), Ven-A-Care of the Florida Keys Inc. (Consolidated Plaintiff).

Anthony J. Anscombe, Sedgwick Detert Moran & Arnold, Chicago, IL, for Ven-Care of the Florida Keys, Inc. (Consolidated Plaintiff), Ven-A-Care of the Florida Keys, Inc. (Plaintiff), Bristol-Myers Squibb Company (Consolidated Defendant).

Justin S. Antonipillai, Arnold & Porter, Washington, DC, for Ethex Corporation (Defendant).

Melissa Aoyagi Davis, Polk & Wardwell, New York, NY, for Ethex Corporation (Defendant), Astrazeneca Pharmaceuticals LP (Defendant).

Martin A. Aronson, Morrill & Aronson, Phoenix, AZ, for Fujisawa Healthcare, Inc. (Consolidated Defendant).

Daniel F. Attridge, Kirkland & Ellis Suite, Washington, DC, for Fujisawa USA, Inc. (Consolidated Defendant), B. Braun Medical Inc. (Defendant).

Megan M. Auchincloss, Morrison & Foerster, LLP, Denver, CO, for B. Braun of America (Defendant), Purdue Pharma L.P. (Defendant).

Pamela J. Auerbach, Kirkland & Ellis LLP, Washington, DC, for Barr Laboratories, Inc. (Consolidated Defendant).

Jennifer Aurora, Sedgwick, Detert, Moran & Arnold LLP, New York, NY, for Organon Pharmaceuticals USA, Inc. (Defendant).

Gary L. Azorsky Berger & Montague, PC, Philadelphia, PA, for Ven-A-Care of the Florida Keys, Inc. (Plaintiff).

Violeta I Balan Mayer, Brown, Rowe & Maw, Drive Chicago, IL, for Ven-A-Care of the Florida Keys Inc. (Consolidated Plaintiff), Ven-A-Care of the Florida Keys, Inc. (Consolidated Plaintiff), Johnson & Johnson (Consolidated Defendant).

Mitchell J. Banas, Jr., Jaeckle Fleischmann & Mugel LLP, Buffalo, NY, for Biogen Idec, Inc. (Consolidated Defendant).

Susan Hughes Banning Hemenway & Barnes, Boston, MA, for Neighborhood Health Plan, Inc. (Movant).

Anita Bapooji Ryan, Goodwin Procter LLP, Boston, MA, for TAP Pharmaceutical Products, Inc. (Defendant).

Jason E. Baranski, Morgan Lewis & Bockius, LLP, Philadelphia, PA, for Pharmacia & Upjohn, Inc. (Defendant).

Scott A. Barbour, McName, Lochner, Titus & Williams, Albany, NY, for Ivax Corp. (Consolidated Defendant).

Steven F. Barley Hogan & Hartson, LLP, Baltimore, MD, for Teva Pharmaceutical USA (Consolidated Defendant), Amgen Inc. (Defendant).

Jessica Vincent Barnett Foley Hoag LLP, Boston, MA, for Astrazeneca Pharmaceuticals LP (Defendant).

Charles Barnhill, Miner, Barnhill & Galland, Madison, WI, for Commonwealth of Kentucky (Consolidated Plaintiff).

Christopher K. Barry-Smith, Office of the Attorney General, Boston, MA, for State of Illinois (Consolidated Defendant), State of Massachusetts (Consolidated Defendant).

Paul S. Battaglia Bond, Schoeneck & King PLLC, Syracuse, NY, for Par Pharmaceutical, Inc. (Consolidated Defendant).

Jon Steven Baughman Ropes & Gray LLP, Washington, DC, for Schering-Plough Corporation (Consolidated Defendant).

Edwin Baum Proskauer, Rose Law Firm, New York, NY, for Warrick Pharmaceuticals Corporation (Consolidated Defendant), Biovail Pharmaceuticals, Inc. (Consolidated Defendant).

P. Ryan Beckett, Butler, Snow, O'Mara, Stevens & Cannada, Jackson, MS, for Eli Lilly and Company (Consolidated Defendant).

Rebecca Bedwell-Coll Mascone, Emblidge & Quadra, San Francisco, CA, for Constance Thompson (Plaintiff).

Stacy D. Belf, Ropes & Gray LLP, Washington, DC, for John B. Rice (Plaintiff), Schering-Plough Corporation (Consolidated Defendant).

Terrianne Benedetto Kline & Specter, Floor Philadelphia, PA, for International Union of Operating Engineers, Local No. 68 Welfare Fund (Consolidated Plaintiff).

Daniel J. Bennett, Ropes & Gray LLP, Boston, MA, for Susan Aaronson Kline & Specter, P.C. (Plaintiff), Schering-Plough Corporation (Consolidated Defendant).

Curtis Bergen, Bowman and Brooke LLP, Phoenix, AZ, for Warrick Pharmaceuticals Corporation (Consolidated Defendant), Baxter Healthcare Corp. (Consolidated Defendant).

Elizabeth M Bergen, Gibson, McAskill Law Firm, Buffalo, NY, for Baxter International, Inc. (Defendant), Abbott Laboratories, Inc. (Consolidated Defendant).

Lawrence D. Berger, Ballard, Spahr, Andrews & Ingersoll, LLP, Philadelphia, PA, for TAP Pharmaceutical Products, Inc. (Consolidated Defendant).

Mark A. Berman, Hartmann Doherty Rosa & Berman, LLC, Hackensack, NJ, for Berlax Laboratories, Inc. (Defendant).

Steve W. Berman, Hagens Berman Sobol Shapiro LLP, Seattle, WA, for Reliant

Pharmaceauticals, LLC (Defendant), Shirley Geller (Consolidated Plaintiff).

David J. Bershad, Milberg Weiss Bershad Hynes & Lerach LLP, New York, NY, for State of Nevada (Plaintiff), State of Montana (Plaintiff), All Plaintiffs (Plaintiff), Government Employees Hospital Association (Consolidated Plaintiff), Pipefitters Local 537 Trust Funds (Plaintiff), Harold Bean (Plaintiff), Arizona, State of (Consolidated Plaintiff), State of Arizona (Consolidated Plaintiff), State of Nevada (Consolidated Plaintiff), Citizens for Consumer Justice (Plaintiff).

Adelina O. Berumen, California Department of Justice Bureau of Medi-Cal Fraud, San Diego, CA, for Colorado Progressive Coalition (Plaintiff), Congress of California Seniors (Plaintiff), Florida Alliance for Retired Americans (Plaintiff), Health Care For All (Plaintiff), Massachusetts Senior Action Council (Plaintiff), Masspirg (Plaintiff), Minnesota Senior Federation (Plaintiff), New Jersey Citizen Action (Plaintiff), New York State Wide Senior Action Council (Plaintiff), Pennsylvania Alliance For Retired Americans (Plaintiff), Vermont Public Interest Research Group (Plaintiff), West Virginia Citizen Action (Plaintiff), Wisconsin Citizen Action (Plaintiff), Citizen Action of New York (Plaintiff), Connecticut Citizen Action Group (Plaintiff), Gray Panthers of Sacramento (Plaintiff), Health Action of New Mexico (Plaintiff), Maine Consumers for Affordable Health Care (Plaintiff), North Carolina Fair Share (Plaintiff), Oregon Health Action Campaign (Plaintiff), Oregon State Public Interest Research Group (Plaintiff), United Senior Action of Indiana, Inc. (Plaintiff), Betty Sicher (Plaintiff), Jack Douglas (Plaintiff), Joan S. Lee (Plaintiff), John Bennett (Plaintiff), Pearl Munic (Plaintiff), Sue Miles (Plaintiff), State of California (Plaintiff).

Aimee E. Bierman, Kirkpatrick & Lockhart Preston Gates Ellis LLP, Boston, MA, for Aventis Behring LLC (Consolidated Defendant).

Brandon L. Bigelow, Bingham McCutchen LLP, Boston, MA, for Hoechst Marion Roussel, Inc. (Consolidated Defendant), Aventis Pharmaceuticals Inc. (Defendant), Hoescht Marion Roussel, Inc. (Defendant), Z.L.B. BEHRING (Intervenor Defendant), Takeda Pharmaceuticals North America, Inc. (Defendant).

Scott A. Birnbaum, Birnbaum & Godkin, LLP, Boston, MA, for Takeda Pharmaceutical Company, Limited (Consolidated Defendant), Ethex Corporation (Defendant).

Sheila L. Birnbaum, Skadden, Arps, Slate, Meagher & Flom, New York, NY, for Ethex Corporation (Defendant), Schering-Plough, Corp. (Defendant).

Donald Wayne Bivens, Meyer Hendricks & Bivens PA, Phoenix, AZ, for Warrick Pharmaceuticals Corporation (Consolidated Defendant), Dey, Inc. (Consolidated Defendant).

Steven E. Bizar Buchanan Ingersoll, P.C., Philadephia, PA, for Amerisource-Bergen Corporation.

Rex Blackburn, Blackburn & Jones, Boise, ID, for Abbott Laboratories, Inc. (Consolidated Defendant).

Sam B. Blair, Jr., Baker, Donelson, Bearman, Caldwell, & Berkowitz, P.C., Memphis, TN, for Monarch Pharmaceuticals, Inc. (Defendant).

Lynn M. Blake, Freidman, Hirschen Law Firm, Albany, NY, for King Pharmaceuticals, Inc. (Defendant), King Pharmaceuticals, Inc. (Consolidated Defendant), Monarch Pharmaceuticals, Inc. (Consolidated Defendant), Eisai, Inc. (Consolidated Defendant).

Lynn M. Blake, Freidman, Hirschen Law Firm, Albany, NY, for Schering-Plough

Corporation (Consolidated Defendant), Warrick Pharmaceuticals Corporation (Consolidated Defendant), Genzyme Corporation (Consolidated Defendant).

Robert P. Blood, Goodwin Procter LLP, Boston, MA, for TAP Pharmaceutical Products, Inc. (Consolidated Defendant).

Elise M. Bloom, Proskauer, Rose Law Firm, New York, NY, for TAP Pharmaceutical Products, Inc. (Defendant), Biovail Pharmaceuticals, Inc. (Consolidated Defendant).

Jack B. Blumenfeld, Morris, Nichols, Arsht, & Tunnell, Wilmington, DE, for Astrazeneca PLC (Consolidated Defendant).

Anthony Bolognese, Bolognese & Associates, Philadelphia, PA, for United Food & Commercial Workers Unions and Employers Midest Health Benefits Fund (Consolidated Plaintiff).

Nancy M. Bonnell, Phoenix, AZ, for Abbott Laboratories (Consolidated Plaintiff).

...

To continue reading

Request your trial
58 cases
  • Staley v. Gilead Scis., Inc.
    • United States
    • U.S. District Court — Northern District of California
    • March 3, 2020
    ...engaged in trade or commerce when it undertakes activities in furtherance of its core mission. ’ " In re Pharm. Indus. Avg. Wholesale Price Litig. , 491 F. Supp. 2d 20, 81 (D. Mass. 2007) (emphasis added; quoting Linkage Corp. v. Trs. of Bos. Univ. , 425 Mass. 1, 26, 679 N.E.2d 191 (1997) )......
  • In re Pharm. Industry Average Wholesale Price Lit., 08-1056.
    • United States
    • U.S. Court of Appeals — First Circuit
    • September 23, 2009
    ...deceptive business practices in violation of Massachusetts General Laws Chapter 93A ("Chapter 93A"). In re Pharm. Indus. Average Wholesale Price Litig., 491 F.Supp.2d 20 (D.Mass.2007). The district court found that AstraZeneca had caused the publication of false and inflated average wholesa......
  • McDermott v. Marcus, Errico, Emmer & Brooks, P.C.
    • United States
    • U.S. District Court — District of Massachusetts
    • November 20, 2012
    ...practices without imposing unnecessary restrictions on ethical debt collectors” ’ ”); In re Pharmaceutical Industry Average Wholesale Price Litigation, 491 F.Supp.2d 20, 84 (D.Mass.2007). Indeed: The types of federal statutes that courts have found to be consumer protection statutes under s......
  • Commonwealth v. Tap Pharm. Prods., Inc.
    • United States
    • Pennsylvania Commonwealth Court
    • August 31, 2011
    ...of the cost is reimbursed by the Plaintiff Agencies. See 42 U.S.C. § 1395 l ; See In re Pharm. Indus. Average Wholesale Price Litig., 491 F.Supp.2d 20, 33 (D.Mass.2007), aff'd, 582 F.3d 156 (1st Cir.2009), cert. dismissed sub. nom., AstraZeneca Pharm. LP v. Blue Cross Blue Shield of Massach......
  • Request a trial to view additional results
1 firm's commentaries
  • FTC's 2012 Green Guides: What Does It Mean For Your Advertising Strategy?
    • United States
    • Mondaq United States
    • October 29, 2012
    ...for liability are different and the plaintiff bears the burden of proof. See, e.g., In re Pharm. Indus. Average Wholesale Price Litig., 491 F. Supp. 2d 20, 84 n.56 (D. Mass. 2007). Second, plaintiffs must have a good faith basis for asserting that a defendant has engaged in false advertisin......
1 books & journal articles
  • Health care fraud.
    • United States
    • American Criminal Law Review Vol. 47 No. 2, March 2010
    • March 22, 2010
    ...760 F.2d 68, 71-72 (3d Cir. 1985) (adopting one purpose test); In re Pharmaceutical Industry Average Wholesale Price Litigation, 491 F. Supp. 2d 20, 44 (D. Mass. 2007) (stating that under anti-kickback statute, offering remuneration to purchaser or referral source is improper if one purpose......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT